[Preliminary clinical studies with a new non-ionic contrast medium (Iopamidol) in intravenous pyelography]. 1984

M Miyakawa, and O Yoshida

The non-ionic and low-osmotic pressure contrast media Iopamilon 370 was used on 20 outpatients who had not been found to have abnormal renal function. The results were compared with those obtained with Urographin (76%), currently used at our department, on 13 of the 20 patients. The nephrograms and renal pelvis obtained using Iopamilon 370 tended to have a clearer contrast than those obtained with Urographin. No side effects were produced.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007479 Iopamidol A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures. B-15,000,B-15000,Gastromiro,Iopamidol, (+-)-Isomer,Iopamidol, (R)-Isomer,Iopamidol, Sodium Salt, (S)-Isomer,Iopamiro,Isovue,Isovue 370,Jopamidol,Niopam,SQ 13,396,Solutrast,Solutrast 370,Solutrast Gastro,B 15,000,B 15000,B15,000,B15000
D007483 Iothalamic Acid A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts. Iotalamic Acid,Methalamic Acid,Angio-Conray,Conray 420,Iodothalamate,Iothalamate,Iothalamic Acid, Calcium (2:1) Salt,Iothalamic Acid, Monosilver (1+) Salt,Iothalamic Acid, Monosodium Salt,Iothalamic Acid, Monosodium Salt, Dimer,Lopamidol,Sodium Iothalamate,Acid, Iotalamic,Acid, Iothalamic,Acid, Methalamic,Angio Conray,AngioConray,Iothalamate, Sodium
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Miyakawa, and O Yoshida
March 1987, Hinyokika kiyo. Acta urologica Japonica,
M Miyakawa, and O Yoshida
November 1983, Nihon geka hokan. Archiv fur japanische Chirurgie,
M Miyakawa, and O Yoshida
January 1983, Diagnostic imaging,
M Miyakawa, and O Yoshida
April 1980, Neuroradiology,
M Miyakawa, and O Yoshida
January 1984, Nihon geka hokan. Archiv fur japanische Chirurgie,
M Miyakawa, and O Yoshida
December 1957, Die Medizinische,
M Miyakawa, and O Yoshida
September 1984, Rinsho hoshasen. Clinical radiography,
M Miyakawa, and O Yoshida
November 1987, Rontgenpraxis; Zeitschrift fur radiologische Technik,
Copied contents to your clipboard!